inert 1 MG Oral Tablet
- RxCUI
- 748797
- RxNorm name
- inert 1 MG Oral Tablet
- Display name
- inert 1 MG Oral Tablet
- Full name
- inert 1 MG Oral Tablet
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:26
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sprintec | NORGESTIMATE AND ETHINYL ESTRADIOL | Preferred Pharmaceuticals, Inc. | 90240210-0bca-4a55-99dc-19f2b40d8e3f | 2026-08-31 | Boxed warning, Warnings, Adverse reactions | 748797 |
| SLYND | DROSPIRENONE | Exeltis USA, Inc. | db32bc55-f295-4d87-9dbb-0a2f45573dcf | 2026-08-27 | Warnings, Adverse reactions | 748797 |
| Isibloom | DESOGESTREL AND ETHINYL ESTRADIOL | Bryant Ranch Prepack | 4a8f278f-f505-4537-8deb-74e8927df8c6 | 2026-08-12 | Boxed warning, Warnings, Adverse reactions | 748797 |
| Estarylla | NORGESTIMATE AND ETHINYL ESTRADIOL | Bryant Ranch Prepack | e0b07fb6-8dbd-4e5d-b589-5191a1dc02ae | 2026-08-12 | Boxed warning, Warnings, Adverse reactions | 748797 |
| DROSPIRENONE AND ETHINYL ESTRADIOL | DROSPIRENONE AND ETHINYL ESTRADIOL | Redpharm Drug | 57d1d945-9fc9-4e79-e063-6294a90a738a | 2026-07-30 | Boxed warning, Warnings, Adverse reactions | 748797 |
| norgestimate and ethinyl estradiol | NORGESTIMATE AND ETHINYL ESTRADIOL | PD-Rx Pharmaceuticals, Inc. | 2385591b-70ee-0577-e063-6394a90a9357 | 2026-07-29 | Boxed warning, Warnings, Adverse reactions | 748797 |
| Desogestrel and Ethinyl Estradiol | DESOGESTREL AND ETHINYL ESTRADIOL | Camber Pharmaceuticals, Inc. | 78454ebf-f1a3-4ca0-b32e-88c51bc57773 | 2026-06-24 | Boxed warning, Warnings, Adverse reactions | 748797 |
| VIORELE | DESOGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL | A-S Medication Solutions | 6422dcc3-959a-4590-9ca8-9dcb58e68253 | 2026-06-23 | Boxed warning, Warnings, Adverse reactions | 748797 |
| MONO-LINYAH | NORGESTIMATE AND ETHINYL ESTRADIOL | A-S Medication Solutions | 2ec8f18f-297c-405f-b191-a40767366bad | 2026-06-23 | Boxed warning, Warnings, Adverse reactions | 748797 |
| Turqoz | NORGESTREL AND ETHINYL ESTRADIOL | A-S Medication Solutions | e7a05138-91a5-4c66-a915-614576e0805a | 2026-05-21 | Boxed warning, Warnings, Adverse reactions | 748797 |
| Kurvelo | LEVONORGESTREL AND ETHINYL ESTRADIOL | Lupin Pharmaceuticals, Inc. | 752f525e-1838-4058-9ab7-2c2d91f86dfd | 2026-05-20 | Boxed warning, Warnings | 748797 |
| DROSPIRENONE AND ETHINYL ESTRADIOL | DROSPIRENONE AND ETHINYL ESTRADIOL | Apotex Corp. | 9187a357-e95d-4733-9627-f19522b86373 | 2026-05-14 | Boxed warning, Warnings, Adverse reactions | 748797 |
| Wera | NORETHINDRONE AND ETHINYL ESTRADIOL | Northstar Rx LLC | 638e4f36-1a27-4220-8ec9-3fa9d9b36c11 | 2026-04-15 | Boxed warning, Warnings, Adverse reactions | 748797 |
| Dasetta 7/7/7 | NORETHINDRONE AND ETHINYL ESTRADIOL | Northstar Rx LLC | da52e74a-1baf-4a33-a068-b49176700320 | 2026-04-14 | Boxed warning, Warnings, Adverse reactions | 748797 |
| Vestura | DROSPIRENONE AND ETHINYL ESTRADIOL | Teva Pharmaceuticals, Inc. | c6f63cc0-11b0-4320-a9ef-5bd5c9b16fd5 | 2026-03-24 | Boxed warning, Warnings, Adverse reactions | 748797 |
| Cryselle | NORGESTREL AND ETHINYL ESTRADIOL | A-S Medication Solutions | f73ece43-6b5f-4abb-ba6d-4d62775f2f8e | 2026-03-03 | Boxed warning, Warnings, Adverse reactions | 748797 |
| Norgestimate and Ethinyl Estradiol | NORGESTIMATE AND ETHINYL ESTRADIOL | A-S Medication Solutions | 35c6507c-555a-45ed-aaf6-8695831de71a | 2026-03-03 | Boxed warning, Warnings, Adverse reactions | 748797 |
| VIENVA TM | LEVONORGESTREL AND ETHINYL ESTRADIOL | A-S Medication Solutions | f6825c1a-ba78-47aa-9622-12e59517ab1a | 2026-03-03 | Warnings, Adverse reactions | 748797 |
| drospirenone and ethinyl estradiol | DROSPIRENONE AND ETHINYL ESTRADIOL | A-S Medication Solutions | 6edead7f-a41f-4d0b-a27a-b2047ed4eea0 | 2026-03-03 | Boxed warning, Warnings, Adverse reactions | 748797 |
| Lutera | LEVONORGESTREL AND ETHINYL ESTRADIOL | Dr. Reddys Laboratories Inc. | 47fc432b-2259-47d2-bba9-5e3aae583990 | 2026-02-13 | Warnings, Adverse reactions | 748797 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 9187a357-e95d-4733-9627-f19522b86373 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 3 | These highlights do not include all the information needed to use DROSPIRENONE and ETHINYL ESTRADIOL tablets safely and effectively. See full prescribing information for DROSPIRENONE and ETHINYL ESTRADIOL tablets. DROSPIRENONE and ETHINYL ESTRADIOL tablets, for oral use Initial U.S. Approval: 2001 | 20260514 |
| c6f63cc0-11b0-4320-a9ef-5bd5c9b16fd5 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 3 | These highlights do not include all the information needed to use VESTURA safely and effectively. See full prescribing information for VESTURA . VESTURA ® (drospirenone and ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 2001 | 20260324 |
| f7f7c073-48e0-4065-970b-8103d76b6eb0 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 3 | These highlights do not include all the information needed to use Tri-Estarylla safely and effectively. See full prescribing information for Tri-Estarylla. Tri-Estarylla ® (norgestimate and ethinyl estradiol, USP) tablets, for oral use Initial U.S. Approval: 1989 | 20260127 |
| d0d2a9e9-e9ce-4a42-b429-5c1f9a544795 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 3 | Zovia® 1/35 (Ethynodiol Diacetate and Ethinyl Estradiol Tablets USP, 1 mg/35 mcg) Rx only | 20251110 |
| bff09a7b-aea6-460b-a263-44576e00f510 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 3 | Azurette ® (Desogestrel and Ethinyl Estradiol Tablets, USP and Ethinyl Estradiol Tablets, USP 0.15 mg/0.02 mg and 0.01 mg) | 20250908 |
| d96f0dd8-4eb9-42f7-ab5e-b5515dcf73d6 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 3 | These highlights do not include all the information needed to use Drospirenone and Ethinyl Estradiol Tablets USP safely and effectively. See full prescribing information for Drospirenone and Ethinyl Estradiol Tablets USP. DROSPIRENONE and ETHINYL ESTRADIOL Tablets USP, 3 mg/0.03 mg, for oral use Initial U.S. Approval: 2001. | 20240422 |
| 1ca12bf6-9583-4578-8411-51ad02a405ec | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 3 | Necon ® (Norethindrone and Ethinyl Estradiol Tablets, USP, 0.5 mg/0.035 mg) | 20240415 |
| a3c0c983-7ec7-244a-e053-2995a90adbe4 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 3 | Norgestimate and Ethinyl Estradiol Tablets, USP These highlights do not include all the information needed to use Norgestimate and Ethinyl Estradiol Tablets, USP safely and effectively. See full prescribing information for Norgestimate and Ethinyl Estradiol Tablets, USP. Initial U.S. Approval: 1989 | 20240110 |
| a3ce752d-58df-363d-e053-2a95a90a5411 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 3 | Norgestimate and Ethinyl Estradiol Tablets, USP These highlights do not include all the information needed to use Norgestimate and Ethinyl Estradiol Tablets, USP safely and effectively. See full prescribing information for Norgestimate and Ethinyl Estradiol Tablets, USP. Initial U.S. Approval: 1989 | 20240110 |
| a3cfd79e-a344-1dfc-e053-2995a90a1ab7 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 3 | Norgestimate and Ethinyl Estradiol Tablets, USP These highlights do not include all the information needed to use Norgestimate and Ethinyl Estradiol Tablets, USP safely and effectively. See full prescribing information for Norgestimate and Ethinyl Estradiol Tablets, USP. Initial U.S. Approval: 1989 | 20240110 |
| dea10e78-0e7b-4404-9c3a-ed2447a1788b | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 3 | Rhuzdah (norethindrone and ethinyl estradiol tablets, USP) 0.4 mg/0.035 mg 28-Day Regimen Rx only | 20231123 |
| 02e5c9a1-6002-499e-abe2-8473a5854178 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 3 | These highlights do not include all the information needed to use NORGESTIMATE AND ETHINYL ESTRADIOL TABLETS safely and effectively. See full prescribing information for NORGESTIMATE AND ETHINYL ESTRADIOL TABLETS. NORGESTIMATE and ETHINYL ESTRADIOL tablets, 0.25 mg/0.035 mg, for oral use NORGESTIMATE and ETHINYL ESTRADIOL tablets, 0.18 mg/0.035 mg, 0.215 mg/0.035 mg, 0.25 mg/0.035 mg, for oral use Initial U.S. Approval: 1989 | 20231004 |
| a1f6ea0e-7c14-47c4-83a2-3797bd012eb4 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 3 | These highlights do not include all the information needed to use DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS safely and effectively. See full prescribing information for DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS. DROSPIRENONE and ETHINYL ESTRADIOL tablets, for oral use Initial U.S. Approval: 2001 | 20230919 |
| ea18ce00-990c-4c02-ae7b-b79a08c6e50c | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 3 | Volnea ® (Desogestrel and Ethinyl Estradiol Tablets, USP and Ethinyl Estradiol Tablets, USP) | 20230911 |
| 653e7f67-67b7-478e-b36b-5e3189d4fe3e | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 3 | These highlights do not include all the information needed to use JASMIEL safely and effectively. See full prescribing information for JASMIEL. JASMIEL ® (drospirenone and ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 2001 | 20230607 |
| 6fc9aa72-6289-4ce1-8b41-b132307564fd | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 3 | Balziva ® (norethindrone and ethinyl estradiol tablets USP ) | 20230607 |
| 8a4aa52f-fe7b-4814-9488-009fddfbfbb1 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 3 | These highlights do not include all the information needed to use Tri-VyLibra safely and effectively. See full prescribing information for Tri-VyLibra. Tri-VyLibra ® (norgestimate and ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 1989 | 20230607 |
| 94a08565-d13c-4784-aab3-c7dac5b2fa31 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 3 | Chateal EQ ® (Levonorgestrel and Ethinyl Estradiol Tablets USP 0.15 mg/0.03 mg) Rx only | 20230607 |
| 9ef8ffe1-5cba-47dc-a405-dd523d76abb5 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 3 | Cryselle ® (norgestrel and ethinyl estradiol tablets USP) | 20230607 |
| a2337cc6-a102-4817-84f4-9491795ab1cc | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 3 | Cyred EQ ® (Desogestrel and Ethinyl Estradiol Tablets USP 0.15 mg/0.03 mg) Rx only | 20230607 |
| e5b71df3-d99e-4e2d-a0cf-4c2790a6907d | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 3 | These highlights do not include all the information needed to use VyLibra safely and effectively. See full prescribing information for VyLibra. VyLibra ® (norgestimate and ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 1989 | 20230607 |
| e7f11ebb-365e-4a31-bf36-6e924251a530 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 3 | Velivet ® (desogestrel and ethinyl estradiol tablets USP - triphasic regimen) Patients should be counseled that this product does not protect against HIV infection (AIDS) and other sexually transmitted diseases. | 20230607 |
| f1fa5297-01d6-4aad-a18e-0518ee8bb419 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 3 | These highlights do not include all the information needed to use JOLESSA safely and effectively. See full prescribing information for JOLESSA . JOLESSA ® (levonorgestrel and ethinyl estradiol tablets) for oral use Initial U.S. Approval: 1982 | 20230607 |
| be557ef8-4e55-4e4a-8971-f5854719ed7a | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 3 | These highlights do not include all the information needed to use ZARAH safely and effectively. See full prescribing information for ZARAH. ZARAH® (drospirenone/ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 2001 | 20201215 |
| d5a2cb17-0807-4529-bd6e-d311e06fc460 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 3 | Zovia ® 1/35E (28 Day Regimen) (ethynodiol diacetate and ethinyl estradiol tablets USP) | 20201215 |
| b0c91536-7874-412d-a488-21d65e7340f5 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 3 | These highlights do not include all the information needed to use NORGESTIMATE AND ETHINYL ESTRADIOL TABLETS safely and effectively. See full prescribing information for NORGESTIMATE AND ETHINYL ESTRADIOL TABLETS. NORGESTIMATE and ETHINYL ESTRADIOL tablets, for oral use Initial U.S. Approval: 1989 | 20200118 |
| c1fc22e5-e02d-4dda-a9ac-c592e922c467 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 3 | Tri-Sprintec ® (norgestimate and ethinyl estradiol tablets USP) | 20200101 |
| d19ff955-1778-43c7-a111-476d740dc9d9 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 3 | These highlights do not include all the information needed to use TRI-LO-MARZIA safely and effectively. See full prescribing information for TRI-LO-MARZIA TRI-LO-MARZIA™ (norgestimate and ethinyl estradiol tablets USP), for oral use Initial U.S. Approval: 1989 | 20191101 |
| 97083436-da10-43da-9181-2d6379be0936 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 3 | These highlights do not include all the information needed to use DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS safely and effectively. See full prescribing information for DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS DROSPIRENONE and ETHINYL ESTRADIOL TABLETS, 3 mg/0.03 mg, for oral use Initial U.S. Approval:2001 | 20190911 |
| ea2fdcc3-f453-45f6-ae34-1bf3a2766eb7 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 3 | These highlights do not include all the information needed to use DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS safely and effectively. See full prescribing information for DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS DROSPIRENONE and ETHINYL ESTRADIOL TABLETS, 3 mg/0.02 mg, for oral use Initial U.S. Approval:2001 | 20190911 |
| 5bebc7e2-d085-410c-bae1-7d758d3c2016 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 2 | Aubra EQ® (Levonorgestrel and Ethinyl Estradiol Tablets USP) 0.1 mg/0.02 mg Rx only Patients should be counseled that oral contraceptives do not protect against transmission of HIV (AIDS) and other sexually transmitted diseases (STDs) such as chlamydia, genital herpes, genital warts, gonorrhea, hepatitis B, and syphilis. | 20250819 |
| 22e5d50a-a772-4e90-82f8-b49ecdf91610 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 2 | Cryselle ® (norgestrel and ethinyl estradiol tablets USP) | 20240408 |
| 198477e0-855a-4a1d-ae0b-407568dd05f8 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 2 | Rx only | 20221208 |
| 0a2775d0-8ca1-457f-9fbe-096f03aedc79 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 2 | Orsythia ® (levonorgestrel and ethinyl estradiol tablets, USP) 0.1 mg/0.02 mg Rx only | 20201225 |
| 0d754d53-2a8b-40c8-9008-64390cd72dd0 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 2 | These highlights do not include all the information needed to use TRI FEMYNOR safely and effectively. See full prescribing information for TRI FEMYNOR. TRI FEMYNOR™ (norgestimate and ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 1989 | 20200118 |
| 18d1c61e-4bce-4535-b8a2-dbde268875d4 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 2 | Orsythia ® (levonorgestrel and ethinyl estradiol tablets, USP) 0.1 mg/0.02 mg Rx only | 20191002 |
| 162540df-d6a5-4c0c-b478-3e7720e7beb6 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 2 | These highlights do not include all the information needed to use PREVIFEM ® or TRI-PREVIFEM ® safely and effectively. See full prescribing information for PREVIFEM ® and TRI-PREVIFEM ® . PREVIFEM ® and TRI-PREVIFEM ® (norgestimate/ethinyl estradiol tablets), for oral use Initial U.S. Approval: 1989 | 20161202 |
| 077bf6ff-afb8-4cb7-9faa-fbb6fd9f037f | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 2 | These highlights do not include all the information needed to use YAZ safely and effectively. See full prescribing information for YAZ. Initial U.S. Approval: 2001 | 20120315 |
| 136b1390-bd47-4671-895a-7f75a1b5688d | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 2 | NECON 7/7/7 ® Tablets (norethindrone/ethinyl estradiol) | 20111006 |
| 4fedeb6a-d99f-43e1-89f3-75818ce919aa | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 2 | OCELLA ™ 28 TABLETS (drospirenone and ethinyl estradiol) | 20110223 |